Michael Wolff was at the "edge of a cliff" when he was diagnosed with a cancer that affects less than 300 patients a year in ...

Emma Dimery joined the clinical trial after running out of treatment options. For two years, she's been cancer free.

Can ctDNA-guided therapy stop cancer’s return, sparing patients unnecessary treatment? A new study suggests it might.

Researchers from the University of Eastern Finland, Aalto University and the University of Oulu have developed a new ...

Galleri blood test detects fifty cancers early via cfDNA analysis for adults 50+ with no symptoms, though not a standard ...

Colorectal cancer has increased significantly over the past 20 years among adults under 50. Now scientists may have ...

Colorectal cancer, long associated with aging, is rising alarmingly in younger adults, especially those born in the 1980s.

At AACR 2025, researchers revealed that a liquid biopsy assay using ctDNA detected colorectal cancer recurrence months before ...

Following the launch of two new cancer tests—plus a third planned for before the end of 2025—Exact Sciences is nudging up its ...

Researchers in Japan have developed a predictive model that could improve treatment decisions for advanced pancreatic cancer ...

Folic acid plays a dual role in breast cancer depending on dose and context. While moderate intake may reduce risk, high ...

The pre-analytical workflow is one of the primary considerations in the successful use of liquid biopsies for cancer ...